colm leonard
@leonardcolm
NHS Consultant Chest Physician; Honorary Professor of Respiratory Medicine; Chief Clinical Officer INFEX Therapeutics: AMR & sustainable antimicrobial pipeline
ID: 1148506492708032512
09-07-2019 08:17:40
93 Tweet
272 Followers
619 Following
Very excited to work with Asian ADVANCE-ID network to plan clinical trials of our novel metallo-beta-lactamase (MBL) inhibitor, MET-X. Antimicrobials targeting MBL mechanism of Gram negative bacterial resistance to antibiotics is key gap in pipeline. David Paterson INFEX Therapeutics